What is the most common clinical use of tumor markers in cancer management?

• A. Staging
• B. Diagnosis
• C. Monitoring
• D. Prognosis

Answer: (C)

The main idea is that tumor markers are most useful for watching how cancer behaves over time. They are used to monitor disease status by tracking changes in marker levels as a patient undergoes therapy, showing whether the tumor burden is shrinking, staying stable, or progressing. Serial measurements help determine response to treatment and can provide an early signal of relapse, guiding decisions about continuing, changing, or stopping therapy and prompting imaging or further evaluation as needed.

However, a single elevated marker isn’t enough to diagnose cancer or to definitively stage the disease, because levels can be influenced by noncancer conditions and vary between individuals. Markers can also have prognostic value in some contexts, but their routine, ongoing role in everyday management is primarily to monitor disease course and treatment response. For example, tracking CA-125 in ovarian cancer or CEA in colorectal cancer illustrates how trends over time inform clinical decisions rather than serve as standalone diagnostic tests.